Agenda

The Event

Over two days, this event will attract over 175 senior-level decision makers working in upstream and downstream production and research from Asia Pacific. This prestigious event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 45 speakers will present a full conference programme covering the topics outlined below.

Day 1 Stream 1-  Upstream Production and Processing & Cell Culture
•    Cell culture automation
•    Optimised cell culture development
•    Upstream technologies e.g. high throughput platforms
•    Cellline expression technologies
•    Media selection & screening methods
•    Process scale up, scale down
•    Optimising Downstream technologies

Day 1 Stream 2 – Protein Purification, Expression & Characterisation
•    Different expression systems
•    Cell line cultivation and development
•    Vector screening
•    Recombinant protein expression
•    Functional characterisation
•    Unfolded proteins
•    Cell free systems
•    Expression, Purification and characterisation technologies
•    Monoclonal Antibodies
•    Antibody engineering
•    Bispecific antibodies and other novel constructs
•    Anti-body drug conjugates
•    Formulation And Stability

Day 2 Stream 1- Bioprocessing & biopharmaceutical manufacturing
•    Biosimilars manufacturing challenges, regulatory models and operational excellence
•    Quality by Design QbD for Biopharmaceuticals
•    Technology Transfer in Biopharmaceuticals
•    Quality Risk Management
•    Development of Biologics
•    Optimal construction for biopharmaceutical facilities
•    Facility utilization
•    Disposables for Biopharmaceutical manufacturing
•    Optimising Biologic Manufacturing Operations through Single-use Technologies Application
•    CMC requirements and regulation for investigational products

Day 2 Stream 2 – Biotherapeutics
•    Extending half life
•    Fab and single chain fragments
•    Hybrid proteins
•    Receptors
•    Chemical biology
•    Alternative scaffolds
•    Protein-protein interaction
•    Manufacturability
•    Recombinent Protein Therapeutics

testimonials_3testimonials_4testimonials_7testimonials_5testimonials_6testimonials_21